Doubly-robust estimator of the difference in restricted mean times lost with competing risks data
出版年份 2022 全文链接
标题
Doubly-robust estimator of the difference in restricted mean times lost with competing risks data
作者
关键词
-
出版物
STATISTICAL METHODS IN MEDICAL RESEARCH
Volume -, Issue -, Pages 096228022211026
出版商
SAGE Publications
发表日期
2022-05-24
DOI
10.1177/09622802221102625
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Estimating restricted mean survival time and expected life-years lost in the presence of competing risks within flexible parametric survival models
- (2021) Sarwar I. Mozumder et al. BMC Medical Research Methodology
- Estimation and modeling of the restricted mean time lost in the presence of competing risks
- (2021) Sarah C. Conner et al. STATISTICS IN MEDICINE
- Fine‐Gray subdistribution hazard models to simultaneously estimate the absolute risk of different event types: Cumulative total failure probability may exceed 1
- (2021) Peter C. Austin et al. STATISTICS IN MEDICINE
- Estimating heterogeneous survival treatment effect in observational data using machine learning
- (2021) Liangyuan Hu et al. STATISTICS IN MEDICINE
- On the empirical choice of the time window for restricted mean survival time
- (2020) Lu Tian et al. BIOMETRICS
- G-computation, propensity score-based methods, and targeted maximum likelihood estimator for causal inference with different covariates sets: a comparative simulation study
- (2020) Arthur Chatton et al. Scientific Reports
- Using simulation studies to evaluate statistical methods
- (2019) Tim P. Morris et al. STATISTICS IN MEDICINE
- Adjusted restricted mean survival times in observational studies
- (2019) Sarah C. Conner et al. STATISTICS IN MEDICINE
- One‐step targeted maximum likelihood estimation for time‐to‐event outcomes
- (2019) Weixin Cai et al. BIOMETRICS
- RESOLVING AN APPARENT PARADOX IN DOUBLY ROBUST ESTIMATORS
- (2018) Alexander P Keil et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Restricted mean survival time: Does covariate adjustment improve precision in randomized clinical trials?
- (2018) Theodore Karrison et al. Clinical Trials
- Improved precision in the analysis of randomized trials with survival outcomes, without assuming proportional hazards
- (2018) Iván Díaz et al. LIFETIME DATA ANALYSIS
- Estimating Treatment Effect With Clinical Interpretation From a Comparative Clinical Trial With an End Point Subject to Competing Risks
- (2018) Lihui Zhao et al. JAMA Cardiology
- Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab
- (2018) David R. Gandara et al. NATURE MEDICINE
- Interpretation of time-to-event outcomes in randomized trials: an online randomized experiment
- (2018) I R Weir et al. ANNALS OF ONCOLOGY
- Balancing Covariates via Propensity Score Weighting
- (2017) Fan Li et al. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION
- Estimation of the cumulative incidence function under multiple dependent and independent censoring mechanisms
- (2017) Judith J. Lok et al. LIFETIME DATA ANALYSIS
- Modeling restricted mean survival time under general censoring mechanisms
- (2017) Xin Wang et al. LIFETIME DATA ANALYSIS
- Causal inference in survival analysis using pseudo-observations
- (2017) Per K. Andersen et al. STATISTICS IN MEDICINE
- Comparison of Treatment Effects Measured by the Hazard Ratio and by the Ratio of Restricted Mean Survival Times in Oncology Randomized Controlled Trials
- (2016) Ludovic Trinquart et al. JOURNAL OF CLINICAL ONCOLOGY
- Beyond Composite Endpoints Analysis: Semicompeting Risks as an Underutilized Framework for Cancer Research
- (2016) Ina Jazić et al. JNCI-Journal of the National Cancer Institute
- Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial
- (2016) Louis Fehrenbacher et al. LANCET
- Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis
- (2016) Peter C. Austin STATISTICS IN MEDICINE
- Beyond Composite Endpoints Analysis: Semicompeting Risks as an Underutilized Framework for Cancer Research
- (2016) Ina Jazić et al. JNCI-Journal of the National Cancer Institute
- Moving Beyond the Hazard Ratio in Quantifying the Between-Group Difference in Survival Analysis
- (2014) Hajime Uno et al. JOURNAL OF CLINICAL ONCOLOGY
- Interpretation of Subgroup Analyses in Randomized Trials: Heterogeneity Versus Secondary Interventions
- (2013) Tyler J. VanderWeele et al. ANNALS OF INTERNAL MEDICINE
- Predicting the restricted mean event time with the subject's baseline covariates in survival analysis
- (2013) L. Tian et al. BIOSTATISTICS
- Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome
- (2013) Patrick Royston et al. BMC Medical Research Methodology
- Pseudo-observations for competing risks with covariate dependent censoring
- (2013) Nadine Binder et al. LIFETIME DATA ANALYSIS
- Decomposition of number of life years lost according to causes of death
- (2013) P. K. Andersen STATISTICS IN MEDICINE
- Double-Robust Semiparametric Estimator for Differences in Restricted Mean Lifetimes in Observational Studies
- (2012) Min Zhang et al. BIOMETRICS
- Doubly Robust Estimation of Causal Effects
- (2011) Michele Jonsson Funk et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- SAS and R functions to compute pseudo-values for censored data regression
- (2008) John P. Klein et al. COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE
- On pseudo-values for regression analysis in competing risks models
- (2008) Frederik Graw et al. LIFETIME DATA ANALYSIS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started